Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFERASIROX vs DELORAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFERASIROX vs DELORAZEPAM: Safety Overview

Metric DEFERASIROX DELORAZEPAM
Total FAERS Reports 11,322 1,744
Deaths Reported 2,661 106
Death Rate 23.5% 6.1%
Hospitalizations 4,008 999
Average Patient Age 49.8 yrs 44.9 yrs
% Female Patients 50.1% 63.9%
FDA Approval Date Apr 11, 2025 N/A
Manufacturer AvKARE N/A
Route ORAL N/A
Marketing Status Prescription N/A